{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Max Healthcare Institute Ltd
P/E at 67.77 vs Industry's 61.54: What the Data Shows for Max Healthcare Institute Ltd
A price-to-earnings ratio of 67.77 against an industry average of 61.54 represents a notable premium for Max Healthcare Institute Ltd. Previously rated Hold by MarketsMOJO, the company’s rating was reassessed on 31 Oct 2025. While the one-year return trails the Sensex by a significant margin, shorter-term performance reveals a more nuanced picture, underscoring a divergence in momentum across timeframes.
P/E at 66.91 vs Industry's 60.79: What the Data Shows for Max Healthcare Institute Ltd
A price-to-earnings ratio of 66.91 against an industry average of 60.79 signals a notable premium for Max Healthcare Institute Ltd. Previously rated Hold by MarketsMOJO, the company’s rating was reassessed on 31 Oct 2025. While the one-year return trails the Sensex by a wide margin, the three-month performance tells a different story, highlighting a complex momentum shift within the stock’s recent trading history.
P/E at 67.47 vs Industry's 60.94: What the Data Shows for Max Healthcare Institute Ltd
A price-to-earnings ratio of 67.47 against an industry average of 60.94 represents a notable premium for Max Healthcare Institute Ltd. Previously rated Hold by MarketsMOJO, the company’s rating was reassessed on 31 Oct 2025. While the one-year return trails the Sensex, shorter-term performance reveals a more nuanced momentum picture, highlighting contrasting trends across timeframes.
P/E at 66.34 vs Industry's 59.34: What the Data Shows for Max Healthcare Institute Ltd
Max Healthcare Institute Ltd, a prominent large-cap hospital sector stock and a constituent of the Nifty 50 index, has recently undergone a notable downgrade in its Mojo Grade from Hold to Sell as of 31 Oct 2025. Despite a modest intraday gain of 1.47% on 4 May 2026, the stock’s performance remains mixed against sector and benchmark indices, reflecting evolving investor sentiment and institutional holding dynamics within the healthcare space.
Max Healthcare Institute Ltd is Rated Sell
Max Healthcare Institute Ltd is rated Sell by MarketsMOJO. This rating was last updated on 31 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
P/E at 67.07 vs Industry's 59.71: What the Data Shows for Max Healthcare Institute Ltd
Max Healthcare Institute Ltd, a prominent large-cap hospital sector stock and a constituent of the Nifty 50 index, has recently undergone a significant rating downgrade from Hold to Sell, reflecting growing concerns over its valuation and near-term performance. Despite its strategic importance within the healthcare industry and its benchmark status, the stock has struggled to keep pace with broader market indices, prompting institutional investors to reassess their holdings.
P/E at 67.02 vs Industry's 59.92: What the Data Shows for Max Healthcare Institute Ltd
A price-to-earnings ratio of 67.02 against an industry average of 59.92 represents a notable premium for Max Healthcare Institute Ltd. Previously rated Hold by MarketsMOJO, the company’s rating was reassessed on 31 Oct 2025. While the one-year return trails the Sensex by 4.73 percentage points, the three-month performance tells a different story with a positive 6.26% gain versus a 6.50% decline in the Sensex, highlighting a divergence in momentum across timeframes.
Max Healthcare Institute Ltd: Technical Momentum Shifts Amid Mixed Market Signals
Max Healthcare Institute Ltd (NSE: MAXHEALTH) has experienced a nuanced shift in its technical momentum, reflecting a transition from bearish to mildly bearish trends. Despite a modest 1.07% gain on 28 Apr 2026, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the recent technical parameter changes, placing them in the context of the company’s price action and broader market performance.
P/E at 66.7 vs Industry's 59.3: What the Data Shows for Max Healthcare Institute Ltd
A price-to-earnings ratio of 66.7 against an industry average of 59.3 indicates a notable premium for Max Healthcare Institute Ltd. Previously rated Hold by MarketsMOJO, the stock’s rating was reassessed on 31 Oct 2025. While the one-year return trails the Sensex, the three-month performance tells a different story, revealing a complex momentum shift within this large-cap hospital sector stock.
Max Healthcare Institute Ltd Declines 0.75% Amid Mixed Technical Signals and Rising Derivatives Activity
Max Healthcare Institute Ltd’s stock closed the week at Rs.999.35, down 0.75% from Rs.1,006.90 last Friday, slightly outperforming the Sensex which fell 1.31% over the same period. The week was marked by mixed technical signals, surging derivatives activity, and cautious investor participation amid a broadly negative market backdrop.
Max Healthcare Institute Ltd Sees Sharp Open Interest Surge Amid Mixed Market Signals
Max Healthcare Institute Ltd has witnessed a notable 16.0% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest decline in the stock price, this spike in open interest coupled with volume patterns suggests evolving directional bets among traders in the hospital sector.
Max Healthcare Institute Ltd Sees Sharp Open Interest Surge Amid Mixed Market Signals
Max Healthcare Institute Ltd has witnessed a notable 14.57% increase in open interest in its derivatives segment, signalling heightened market activity despite a modest decline in its share price. This surge in open interest, coupled with volume and price dynamics, offers insights into evolving market positioning and potential directional bets on the large-cap hospital stock.
Max Healthcare Sees Sharp Open Interest Surge Amid Mixed Market Signals
Max Healthcare Institute Ltd (MAXHEALTH) has witnessed a notable 11.35% increase in open interest in its derivatives segment, signalling heightened market activity and shifting positioning among traders. Despite this surge, the stock’s price movement remains subdued, reflecting a complex interplay of investor sentiment and sector dynamics.
P/E at 67.1 vs Industry's 59.56: What the Data Shows for Max Healthcare Institute Ltd
A price-to-earnings ratio of 67.1 against an industry average of 59.56 represents a significant premium for Max Healthcare Institute Ltd. Previously rated Hold by MarketsMOJO, the stock’s rating was reassessed on 31 Oct 2025. While the one-year return trails the Sensex, shorter-term performance reveals a more nuanced momentum picture.
Max Healthcare Institute Sees Sharp Open Interest Surge Amid Mixed Market Signals
Max Healthcare Institute Ltd (MAXHEALTH) has witnessed a notable 13.5% increase in open interest in its derivatives segment, signalling heightened market activity and shifting positioning among traders. Despite a modest price gain of 0.33% on 23 Apr 2026, the stock’s mixed technical indicators and falling investor participation suggest a complex outlook for this large-cap hospital sector player.
Max Healthcare Institute Ltd Sees Significant Open Interest Surge Amid Mixed Market Signals
Max Healthcare Institute Ltd (MAXHEALTH) has witnessed a notable 10.47% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this surge, the stock’s price movement and volume patterns suggest a complex interplay of bullish and bearish sentiments within the hospital sector.
Max Healthcare Institute Ltd Sees Sharp Open Interest Surge Amid Mixed Market Signals
Max Healthcare Institute Ltd (MAXHEALTH) has witnessed a notable surge in open interest in its derivatives segment, signalling increased market activity and shifting investor positioning. Despite this, the stock has underperformed its sector and broader indices, reflecting a complex interplay of market sentiment and technical factors.
Max Healthcare Institute Ltd Faces Bearish Momentum Amid Technical Downgrade
Max Healthcare Institute Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. This downgrade, reflected in the company’s MarketsMOJO grade moving from Hold to Sell as of 31 Oct 2025, underscores growing caution among investors amid weakening price action and mixed technical signals.
Max Healthcare Institute Ltd Sees Mixed Technical Signals Amid Mild Momentum Shift
Max Healthcare Institute Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from bearish to mildly bearish trends. Despite a modest day gain of 1.10%, the stock’s technical parameters reveal a complex picture that investors should carefully analyse amid broader market movements.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
